Larry Smith - Concepedia

Author

Larry Smith

Vical (United States)ORCID

Also Known As

L R SMITH, L R Smith, L SMITH, L Smith, L. R. Smith, L. Ripley Smith, L. SMITH, L. Smith, L.R. Smith, L.Ripley Smith

184

Publications

3.7K

Citations

H-Index

133

Concepts

All Affiliations

Vical (United States)Response Technologies (United States)Loyola University Chicago Pearl River Community College Fred Hutch Cancer Center

About

Larry Smith is an author at Vical (United States) specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	19	1.2K
2	Education	7	7	229
3	Management	3	3	82
4	Business	2	2	60
5	Engineering	2	2	38

Larry Smith

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans Matthew R. Sandbulte, Gretchen S. Jimenez, Adrianus C. M. Boon, PLoS Medicine	2007	290
School leadership in times of crisis Larry Smith, Dan Riley School Leadership and Management	2012	266
CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Jennie C.C. Chang, Larry Smith, Karen Froning, Proceedings of the National Academy of Sciences V BetaImmunologyImmune RegulationPathologyPsoriatic Lesions	1994	233
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial Mohamed A. Kharfan‐Dabaja, Michael Boeckh, Marissa B. Wilck, The Lancet Infectious Diseases	2012	229
Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine Markwin P. Velders, Sanne Weijzen, Gretchen L. Eiben, The Journal of Immunology	2001	185
Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin Larry Smith, Mary K. Wloch, Ming Ye, Vaccine VaccinationCross-protectionVaccine DevelopmentImmunologyClinical Trials	2010	141
Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects Mary K. Wloch, Larry Smith, Souphaphone Boutsaboualoy, The Journal of Infectious Diseases	2008	139
Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA. Markwin P. Velders, Sue P. McElhiney, M. Cristina Cassetti, PubMed Veterinary VaccineHpv16 E7 RnaImmunologyHuman Papillomavirus 16Pathology	2001	136
Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes M. Cristina Cassetti, Sue P. McElhiney, Vafa Shahabi, Vaccine VaccinationE7 GenesMolecular VirologyHpv16 E6Immunology	2003	112
Vaxfectin™-Formulated Influenza DNA Vaccines Encoding NP and M2 Viral Proteins Protect Mice against Lethal Viral Challenge Gretchen S. Jimenez, Rodrick Planchon, Qun Wei, Human Vaccines	2007	85

Page 1